Monahan Joseph
SEC insider (Form 3/4/5 filer). CIK 0001861790. Chief Scientific Officer at Aclaris Therapeutics, Inc. (ACRS). 14 reported Form 4/5 transactions since Sep 2024; latest on Mar 1, 2025. Located in WAYNE, PA.
Companies Monahan Joseph has filed insider reports for
- Aclaris Therapeutics, Inc. (ACRS): Officer, Chief Scientific Officer
Monahan Joseph
CIK: 0001861790
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
Aclaris Therapeutics, Inc.
Discretionary Trading P&L
Holdings
Transaction History (14 total)
- Mar 1, 2025ACRS
Aclaris Therapeutics, Inc.
ExerciseDirect50K shares- - Mar 1, 2025ACRS
Aclaris Therapeutics, Inc.
ExerciseDirect10.9K shares- - Mar 1, 2025ACRS
Aclaris Therapeutics, Inc.
Tax PaymentDirect27.3K shares at avg. $1.99$54K - Feb 3, 2025ACRS
Aclaris Therapeutics, Inc.
AwardDirectEmployee Stock Option (Right to Buy)
293.5K shares- - Feb 3, 2025ACRS
Aclaris Therapeutics, Inc.
AwardDirectRestricted Stock Units
83.9K shares- - Feb 1, 2025ACRS
Aclaris Therapeutics, Inc.
Tax PaymentDirect11.3K shares at avg. $2.48$28K - Feb 1, 2025ACRS
Aclaris Therapeutics, Inc.
ExerciseDirect14.8K shares- - Feb 1, 2025ACRS
Aclaris Therapeutics, Inc.
ExerciseDirect7.5K shares- - Jan 2, 2025ACRS
Aclaris Therapeutics, Inc.
AwardDirectRestricted Stock Units
52.7K shares- - Jan 2, 2025ACRS
Aclaris Therapeutics, Inc.
ExerciseDirect17.4K shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Mar 1, 2025 | ACRS Aclaris Therapeutics, Inc. | Exercise | 50,000 | - | - | Direct |
| Mar 1, 2025 | ACRS Aclaris Therapeutics, Inc. | Exercise | 10,925 | - | - | Direct |
| Mar 1, 2025 | ACRS Aclaris Therapeutics, Inc. | Tax Payment | 27,258 | $1.99 | $54,243 | Direct |
| Feb 3, 2025 | ACRS Aclaris Therapeutics, Inc. | Award Employee Stock Option (Right to Buy) | 293,500 | - | - | Direct |
| Feb 3, 2025 | ACRS Aclaris Therapeutics, Inc. | Award Restricted Stock Units | 83,900 | - | - | Direct |
| Feb 1, 2025 | ACRS Aclaris Therapeutics, Inc. | Tax Payment | 11,317 | $2.48 | $28,066 | Direct |
| Feb 1, 2025 | ACRS Aclaris Therapeutics, Inc. | Exercise | 14,750 | - | - | Direct |
| Feb 1, 2025 | ACRS Aclaris Therapeutics, Inc. | Exercise | 7,500 | - | - | Direct |
| Jan 2, 2025 | ACRS Aclaris Therapeutics, Inc. | Award Restricted Stock Units | 52,667 | - | - | Direct |
| Jan 2, 2025 | ACRS Aclaris Therapeutics, Inc. | Exercise | 17,380 | - | $0 | Direct |
1-10 of 14 transactions